These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 2556978

  • 1. Polyvalent immune globulin and cytomegalovirus infection after renal transplantation.
    Kasiske BL, Heim-Duthoy KL, Tortorice KL, Ney AL, Odland MD, Rao KV.
    Arch Intern Med; 1989 Dec; 149(12):2733-6. PubMed ID: 2556978
    [Abstract] [Full Text] [Related]

  • 2. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.
    Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL, Levey AS.
    N Engl J Med; 1987 Oct 22; 317(17):1049-54. PubMed ID: 2821397
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incidence of cytomegalovirus-infection after renal transplantation and first experiences with prophylactic hyperimmunoglobulin.
    Fassbinder W, Bechstein PB, Scheuermann EH, Schoeppe W.
    Scand J Urol Nephrol Suppl; 1985 Oct 22; 92():23-8. PubMed ID: 3008313
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N, Holman MJ, Yang HC.
    Clin Transplant; 1997 Dec 22; 11(6):633-9. PubMed ID: 9408699
    [Abstract] [Full Text] [Related]

  • 9. [Cytomegalovirus (CMV) infection: a frequent and life-threatening complication in heart transplant patients].
    Mohacsi P, Leonardi L, Waser M, Lüthy A, Laske A, Turina M, Gallino A.
    Ther Umsch; 1990 Feb 22; 47(2):157-63. PubMed ID: 2156344
    [Abstract] [Full Text] [Related]

  • 10. Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG.
    Dreikorn K, Doerr HW, Geursen RG.
    Scand J Urol Nephrol Suppl; 1985 Feb 22; 92():15-21. PubMed ID: 3008312
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Complications of infections attributed to cytomegalovirus in a group of 52 kidney transplant patients].
    Galezowski N, Godeaut E, Berche P, Bonissol C, Debure A, Kreis H.
    Ann Med Interne (Paris); 1987 Feb 22; 138(5):369-71. PubMed ID: 2823666
    [Abstract] [Full Text] [Related]

  • 13. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
    Baldwin WM, van Es A, Valentijn RM, van Gemert GW, Daha MR, Vanes LA.
    Clin Exp Immunol; 1982 Dec 22; 50(3):515-24. PubMed ID: 6299633
    [Abstract] [Full Text] [Related]

  • 14. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ, Malaise J, Moreno A, Crespo M, Fernández-Cruz L, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May 22; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [Abstract] [Full Text] [Related]

  • 15. [Relationship between the symptomatic cytomegalovirus infection and the fluctuation of anti-CMV antibodies in patient after renal transplantation].
    Miyamoto N, Takamura Y.
    Rinsho Byori; 1992 Feb 22; 40(2):189-93. PubMed ID: 1316499
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J.
    Rev Invest Clin; 2002 Feb 22; 54(3):198-203. PubMed ID: 12183888
    [Abstract] [Full Text] [Related]

  • 19. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E, Lanio N, Gallego A, Rodriguez-Molina J, Navarro J, Fernandez-Yañez J, Palomo J, Rodríguez-Hernández C, Ruiz M, Alonso R, Fernandez-Cruz E, Carbone J.
    Int Immunopharmacol; 2009 Jun 22; 9(6):649-52. PubMed ID: 18940269
    [Abstract] [Full Text] [Related]

  • 20. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
    Pavlopoulou ID, Syriopoulou VP, Chelioti H, Daikos GL, Stamatiades D, Kostakis A, Boletis JN.
    Clin Microbiol Infect; 2005 Sep 22; 11(9):736-43. PubMed ID: 16104989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.